title: Neoadjuvant chemotherapy fails to improve survival in advanced ovarian cancer: but is it the real culprit?
authors.forename: Angelo
authors.initials: A
authors.lastname: Di Giorgio
authors.forename: Paolo
authors.initials: P
authors.lastname: Sammartino
authors.forename: Daniele
authors.initials: D
authors.lastname: Biacchi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077216:Carcinoma, Ovarian Epithelial; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D011379:Prognosis; D016019:Survival Analysis; D017211:Treatment Failure